6
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      Are you tired of sifting through news that doesn't interest you?
      Personalize your Karger newsletter today and get only the news that matters to you!

      Sign up

      • Record: found
      • Abstract: found
      • Article: found

      MRI of Blood Volume and Cellular Uptake of Superparamagnetic Iron in an Animal Model of Choroidal Melanoma

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Functional magnetic resonance imaging (MRI), using monocrystalline iron oxide nanoparticles (MION) as a new intravascular contrast agent, was adapted for a rabbit model of pigmented choroidal melanoma. Three-dimensionally spoiled gradient recalled sequences were used for the quantitative assessment of blood volume and cellular uptake. In all ocular tissues studied, MION reduced the T<sub>2</sub>-weighted signal intensity within 0.5 h and at 24 h (both p < 0.05) after the injection. In individual tumors, MION reduced the T<sub>2</sub>-weighted signal intensity by 46–78% within 0.5 h and by 24–48% at 24 h. In addition, MION increased the T<sub>1</sub>-weighted signal intensity in all tissues. T<sub>2</sub> yielded a higher sensitivity than T<sub>1</sub>-weighted images. Functional MRI with MION is a noninvasive technique with regard to the eye, permitting measurement of blood volume and cellular uptake of the contrast agent. Further study is necessary to determine the feasibility of this technique for the tumor diagnosis and evaluation of tumor viability following treatments.

          Related collections

          Author and article information

          Journal
          ORE
          Ophthalmic Res
          10.1159/issn.0030-3747
          Ophthalmic Research
          S. Karger AG
          0030-3747
          1423-0259
          2002
          August 2002
          16 September 2002
          : 34
          : 4
          : 241-250
          Affiliations
          aMassachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Boston, Mass., and bMassachusetts General Hospital-Nuclear Magnetic Resonance Center, Harvard Medical School, Charlestown, Mass., USA
          Article
          63883 Ophthalmic Res 2002;34:241–250
          10.1159/000063883
          12297697
          81e8a2aa-2eff-4282-9f70-888cfb1bb446
          © 2002 S. Karger AG, Basel

          Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

          History
          : 30 October 2001
          : 18 February 2002
          Page count
          Figures: 5, Tables: 2, References: 67, Pages: 10
          Categories
          Original Paper

          Vision sciences,Ophthalmology & Optometry,Pathology
          Blood volume,Pharmacokinetics,Pathology,Diagnostic use,Nuclear magnetic resonance,Ferric compounds,Physiopathology,Melanoma,Choroid neoplasms

          Comments

          Comment on this article